The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease
- PMID: 9681968
- DOI: 10.1016/s0306-4522(97)00697-0
The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease
Comment on
-
Using okadaic acid as a tool for the in vivo induction of hyperphosphorylated tau.Neuroscience. 1998 Aug;85(4):1329-32. doi: 10.1016/s0306-4522(97)00695-7. Neuroscience. 1998. PMID: 9681966 No abstract available.
-
Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology.Neuroscience. 1998 Aug;85(4):1333-5. doi: 10.1016/s0306-4522(97)00696-9. Neuroscience. 1998. PMID: 9681967 No abstract available.
Similar articles
-
Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology.Neuroscience. 1998 Aug;85(4):1333-5. doi: 10.1016/s0306-4522(97)00696-9. Neuroscience. 1998. PMID: 9681967 No abstract available.
-
Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species.J Neurosci Methods. 2019 May 1;319:60-68. doi: 10.1016/j.jneumeth.2018.09.030. Epub 2018 Sep 29. J Neurosci Methods. 2019. PMID: 30278184 Free PMC article.
-
Using okadaic acid as a tool for the in vivo induction of hyperphosphorylated tau.Neuroscience. 1998 Aug;85(4):1329-32. doi: 10.1016/s0306-4522(97)00695-7. Neuroscience. 1998. PMID: 9681966 No abstract available.
-
Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response.FEBS Lett. 2004 Jan 16;557(1-3):1-8. doi: 10.1016/s0014-5793(03)01447-9. FEBS Lett. 2004. PMID: 14741332 Review.
-
Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?Toxins (Basel). 2013 Feb 4;5(2):267-85. doi: 10.3390/toxins5020267. Toxins (Basel). 2013. PMID: 23381142 Free PMC article. Review.
Cited by
-
Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner.Brain Res. 2010 Jul 23;1345:176-81. doi: 10.1016/j.brainres.2010.04.074. Epub 2010 May 7. Brain Res. 2010. PMID: 20457142 Free PMC article.
-
Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors.Sci Rep. 2012;2:480. doi: 10.1038/srep00480. Epub 2012 Jun 29. Sci Rep. 2012. PMID: 22761989 Free PMC article.
-
A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer's disease.Cell Death Dis. 2025 Apr 15;16(1):300. doi: 10.1038/s41419-025-07611-2. Cell Death Dis. 2025. PMID: 40234443 Free PMC article.
-
Monascus pigment rubropunctatin derivative FZU-H reduces Aβ(1-42)-induced neurotoxicity in Neuro-2A cells.RSC Adv. 2018 May 14;8(31):17389-17398. doi: 10.1039/c8ra02365d. eCollection 2018 May 9. RSC Adv. 2018. PMID: 35539257 Free PMC article.
-
An okadaic acid-induced model of tauopathy and cognitive deficiency.Brain Res. 2010 Nov 4;1359:233-46. doi: 10.1016/j.brainres.2010.08.077. Epub 2010 Aug 31. Brain Res. 2010. PMID: 20807517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical